Shigenori Nozawa

This inventor holds 13 USPTO granted patents and 1 published patent application, plus 2 CIPO patents and 11 EPO patents. Top assignees: Terumo Kabushiki Kaisha, Kabushiki Kaisha Yakult Honsha, Kyoto University. Active years: 1993-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shigenori Nozawa. Retrieved from https://idiyas.com/inventor/shigenori-nozawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 1)

% Patents Active = 92.3

CIPO Patents = 2

EPO Patents = 11 (Patent Applications = 5)

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 39(Granted Patents)

Location History:

Ashigarakami-gun, JP (2017 - 2019)
Kanagawa, JP (1993 - 2020)

Company Filing History:

12 out of 2,424

Terumo Kabushiki Kaisha

patents

1 out of 215

Kabushiki Kaisha Yakult Honsha

where one patent can have more than one assignee

Years Active: 1993-2020

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10835643 - Drug coating layer (2020-11-17),

2. 10188771 - Method of treating peripheral artery diseases in lower limbs (2019-01-29),

3. 10149925 - Method of reducing the risk of embolization of peripheral blood vessels (2018-12-11),

4. 10143779 - Method of inhibiting thickening of vascular intima (2018-12-04),

5. 10045960 - Coating composition and medical device (2018-08-14),

6. 9981070 - Coating composition and medical device (2018-05-29),

7. 9877918 - Long-lasting controlled-release liposome composition and method for producing same (2018-01-30),

8. 9872940 - Drug coating layer (2018-01-23),

9. 9603974 - Coating composition and medical device (2017-03-28),

10. 9592322 - Coating composition and medical device (2017-03-14),

11. 8945526 - Amphiphilic substance, and drug delivery system and molecular imaging system using the same (2015-02-03),

12. 7846473 - Irinotecan preparation (2010-12-07),

13. 5190961 - Thiourea derivatives and antimicrobial agent and antulcer agent (1993-03-02),

Title: Shigenori Nozawa: Innovator in Medical Device Technology

Introduction

Shigenori Nozawa is a prominent inventor based in Kanagawa, Japan. He has made significant contributions to the field of medical devices, particularly in drug delivery systems. With a total of 13 patents, his work has had a substantial impact on the treatment of various medical conditions.

Latest Patents

One of his latest patents is a drug coating layer designed for a non-porous nylon elastomer balloon substrate surface. This innovative coating comprises a plurality of elongated bodies formed from a water-insoluble drug. The design allows for low toxicity and a high intravascular stenosis inhibitory effect. Another notable patent involves a method for treating peripheral artery diseases in lower limbs. This method utilizes a medical device with an expandable member that features a drug coating layer. The coating includes uniformly sized crystal particles of a water-insoluble drug, which are transferred to the blood vessel wall during the procedure, ensuring effective treatment.

Career Highlights

Shigenori Nozawa has worked with several reputable companies throughout his career. Notably, he has been associated with Terumo Corporation and Yakult Honsha Co., Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking innovations in medical technology.

Collaborations

Throughout his career, Nozawa has collaborated with talented individuals such as Keiko Yamashita and Katsumi Morimoto. These partnerships have fostered a creative environment that has led to the development of his innovative patents.

Conclusion

Shigenori Nozawa's contributions to medical device technology exemplify the importance of innovation in healthcare. His patents reflect a commitment to improving patient outcomes through advanced drug delivery systems. His work continues to inspire future advancements in the field.

Profile summary based on public USPTO records.